NIT 2018 IN
Certain Nitisinone Capsules
Notice of Final Determination

Ottawa, March 20, 2019

On March 20, 2019, the Canada Border Services Agency (CBSA), pursuant to paragraph 41(1)(b) of the Special Import Measures Act (SIMA), made a final determination of dumping in respect of certain nitisinone capsules from Sweden.

The subject goods are usually classified under the following tariff classification numbers:

Note that the tariff classification numbers are for convenience of reference only. Refer to the product definition for authoritative details regarding the subject goods.

The Canadian International Trade Tribunal (CITT) is continuing its inquiry into the question of injury to the domestic industry and will make an order or finding by April 18, 2019.

Additional information about these investigations is contained in a Statement of Reasons, which will be available within 15 days on the CBSA’s website at: https://www.cbsa-asfc.gc.ca/sima-lmsi/.

For additional information regarding the application of provisional duties on subject goods imported into Canada, please refer to the following link which contains contact information of CBSA Enforcement officers: https://www.cbsa-asfc.gc.ca/sima-lmsi/mif-mev/menu-eng.html.

Officers' names and contact information:

  • Hugo Dumas: 613-954-7262
  • Jonathan Thiffault: 613-948-7809

E-mail:

Margin of Dumping by Exporter

Exporter Margin of Dumping*
Swedish Orphan Biovitrum AB 1,594%
All Other Exporters N/A

*Expressed as a percentage of export price

Note: The margin of dumping reported in the table above is the margin determined by the Canada Border Services Agency (CBSA) for purposes of the final determination of dumping. This margin does not reflect the anti-dumping duty to be levied on future importations of dumped goods. In the event of an injury finding by the Canadian International Trade Tribunal, normal values have been provided to the exporter who provided sufficient information for future shipments to Canada and these normal values would come into effect the day after the injury finding. Information regarding normal values of the subject goods should be obtained from the exporter. Imports of subject goods from exporters/producers that did not provide sufficient information to the CBSA during the dumping investigation and who are not listed in the table above will be subject to the All Other Exporters anti-dumping duty rate pursuant to a ministerial specification.

Normally, normal values will not be applied retroactively. However, this measure may be applied retroactively in cases where the parties have not advised the CBSA in a timely manner of substantial changes that affect values for SIMA purposes. Therefore, where substantial changes occur in prices, market conditions, costs associated with production and sales of the goods, the onus is on the concerned parties to advise the CBSA.

Please consult the SIMA Self-Assessment Guide for more detailed information explaining how to determine the amount of SIMA duties owing.

Appendix 1

Product Definition

For the purpose of the dumping investigation, the subject goods are defined as:

Capsules and tablets of nitisinone with a dosage of 2 mg, 5 mg, 10 mg and 20 mg, whether or not they are packaged for retail, originating in or exported from the Kingdom of Sweden.

Date modified: